Åse Rosenqvist

Nordic Business Unit Lead Cell Therapy • Janssen

Mrs. Rosenqvist holds a position on the Board of CAMP ATMP Sweden and serves as the Nordic Cell Therapy lead at Janssen, a division of Johnson&Johnson. Her expertise lies in guiding pharmaceutical companies toward innovative approaches in Europe. She excels at fostering collaboration among various stakeholders within the healthcare system, academia, universities, authorities, and the life science sector. Through her inclusive and inspiring leadership style, she empowers individuals and harnesses their potential.

Also speaking

Ohad Karnieli

Founder & Chief Executive Officer • Adva Biotechnology

Sebastian Brunemeier

General Partner • Healthspan Capital

Elisabetta Zanon

Director of EU Public Affairs & Advocacy • Alliance for Regenerative Medicine

Event Info


Innovation Zone

Find out more about the Innovation Zone at Advanced Therapies Europe.

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.